Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2647 - Colon Cancer Screening by Fecal Immunochemical Testing in Iran


10 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Cancer Prevention;  Colon and Rectal Cancer


Hamideh Salimzadeh


Annals of Oncology (2017) 28 (suppl_5): v502-v506. 10.1093/annonc/mdx383


H. Salimzadeh1, F. Bishehsari2, C. Sauvaget3, M. Amani1, R. Hamzeloo4, A. Nikfarjam4, M. Maziar4, S. Merat1, A. Delavari1, R. Malekzadeh1

Author affiliations

  • 1 Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, 1411713135 - Tehran/IR
  • 2 Department Of Internal Medicine, Division Of Gastroenterology, Rush University Medical Center, Chicago/US
  • 3 3. screening Group, Early Detection And Prevention, International Agency for Research on Cancer, Lyon/FR
  • 4 Health Deputy, Tehran University of Medical Sciences, Tehran/IR


Abstract 2647


Colorectal cancer (CRC) is the third-most common cancer in Iran. We aimed to measure the uptake and feasibility of a pilot CRC screening programme based on fecal immunochemical test (FIT) in population aged between 45 and 75 years and the implications for scaling-up at the national level.


This pilot study was conducted in Tehran and individuals aged between 45 and 75 years in rural and urban areas were enrolled in the screening programme. The FIT was offered by health navigators in primary health centers by collecting one single sample directly in to buffer kits by each participant. Health navigators aimed at increasing uptake and handled the whole screening programme from invitation to the referrals and provided the participants with information regarding the nature and importance of the CRC screening and details as to how to collect stool samples and send them back to the laboratory for analysis. If the first kit was not returned within 48 hours, a reminder call was sent. Those participants who had a positive FIT were referred to undergo a colonoscopy.


A total of 1044 asymptomatic average-risk individuals were enrolled. The age mean was 54.1 and nearly 63.0% (n = 657) were female. Only small fraction of participants had awareness about CRC (13.7%) or polyps (8.3%) or screening tests (9.2%). Likewise their prior screening practice was extremely weak (2.2%). In multivariate regression analysis, awareness about CRC and screening tests significantly varied according to the ethnic groups, years of schooling, and family history of cancers (P 


This is the first study on minimal quality metrics within a CRC screening process for the pilot phase and indicates that FIT modality as a test of choice is a safe and highly acceptable method of CRC screening in average-risk asymptomatic people. We suggest FIT as an initial CRC screening tool along with other preventive services in primary health care system in the nation.

Clinical trial identification


Legal entity responsible for the study

Prof. Reza Malekzadeh




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.